Chronic inflammatory demyelinating polyradiculoneuropathy: Diagnostic strategy. Guidelines of the French CIDP study group;Pratique neurologique: Polyradiculonévrites inflammatoires démyélinisantes chroniques: Stratégie diagnostique. Recommandations du groupe d'Étude Français des PIDC

Revue Neurologique

Volumn 161, Issue 10, 2005, Pages 988-996

  Antoine, J C ^b   Azulay, J P ^b   Bouche, P ^b   Creange A ^b   Fournier, E ^b   Gallouedec, G ^b   Lagueny, A ^b   Lefaucheur, J P ^b   Leger J M ^b   Magy, L ^b   Maisonobe, T ^b   Nicolas, G ^b   Pouget, J ^b   Soichot, P ^b   Stojkovic, T ^b   Vallat, J M ^a   Verschueren, A ^b   Vial, C ^b   Viala, K ^b  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

Chronic inflammatory demyelinating polyradiculoneuropathy; CIDP; Diagnostic strategy

Indexed keywords

IMMUNOMODULATING AGENT;

CLINICAL FEATURE; DEMYELINATING DISEASE; DRUG EFFICACY; ELECTROMYOGRAPHY; ELECTRONEUROGRAPHY; ELECTROPHYSIOLOGY; FRANCE; HUMAN; IMMUNOPATHOLOGY; NERVE BIOPSY; POLYRADICULONEUROPATHY; PRACTICE GUIDELINE; REVIEW; ARTICLE;

HUMANS; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING;

EID: 27144521631     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. AD HOC SUBCOMMITTEE OF THE AMERICAN ACADEMY OF NEUROLOGY AIDS TASK FORCE. (1991). Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology, 41: 617-618.
2. ALBERS JW, KELLY JJ. (1989). Acquired inflammatory demyelinated polyneuropathies: clinical and electrophysiological features. Muscle Nerve, 12: 435-451.
3. ANTOINE JC, MOSNIER JF, LAPRAS J, CONVERS P, ABSI L, LAURENT B et al. (1996). Chronic inflammatory demyelinating polyneuropathy associated with carcinoma. J Neurol Neurosurg Psychiatry, 60: 188-190.
4. ATTARIAN S, AZULAY JP, BOUCRAUT J, ESCANDE N, POUGET J. (2001). Terminal latency index and modified F ratio in distinction of chronic demyelinating neuropathies. Clin Neurophysiol, 112: 457-463.
5. AYYAR DR, SHARMA KR. (2004). Chronic inflammatory demyelinating polyradiculoneuropathy in diabetes mellitus. Curr Diab Rep, 4: 409-412.
6. BARNES D, HAMMAN SR, LEGG HNJ. (1988). Chronic relapsing inflammatory polyneuropathy complicating sicca syndrome. J Neurol Neurosurg Psychiatry, 51: 159-160.
7. BAROHN RJ, KISSEL JT, WARNOLTS JR, MENDELL JR. (1989). Chronic inflammatory demyelinating polyradiculoneuropathy. Arch Neurol, 46: 878-884.
8. BOSBOOM WMJ, VAN DEN BERG LH, FRANSSEN H, GIESBERGEN PC, FLACH HZ, VAN PUTTEN AM et al. (2001). Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy. Brain, 124: 2427-2438.
9. BROMBERG MB. (1991). Comparaison of electrodiagnostic criteria for primary demyelinating in chronic polyneuropathy. Muscle Nerve, 14: 968-976.
10. BUSBY M, DONAGHY M. (2003). Chronic dysimmune neuropathy. J Neurol, 250: 714-724.
11. CACOUB P, SBAÏ A, WECHSLER B, MAISONOBE T, PARISER P, PIETTE JC. (1999). Polyradiculonévrite inflammatoire chronique et virus de l'hépatite C. Rev Med Interne, 20: 1146-1151.
12. CHASSANDE B, LÉGER JM, BEN-YOUNES-CHENOUFI A et al. (1998). Peripheral neuropathy associated with IgM monoclonal gammopathy: correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases. Muscle Nerve, 21: 55-62.
13. CHIN RL, LATOV N, SANDER HW, HAYS AP, CROUL SE, MAGDA P et al (2004). Sensory CIDP presenting as cryptogenic sensory polyneuropathy. J Peripher Nerv Syst, 9: 132-137.
14. CZAPLINSKI A, STECK AJ. (2004). Immune mediated neuropathies - an update on therapeutic strategies. J Neurol, 251: 127-137.
15. DONOFRIO PD. (2003). Immunotherapy of idiopathic inflammatory neuropathies. Muscle Nerve, 28: 273-292.
16. DUGGINGS AJ, MCLEOD JG, POLLARD JD, DAVIES L, YANG F, THOMPSON EO et al. (1999). Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy. Brain, 122: 1383-1390.
17. DYCK PJ, LAIS AC, OTHA M, BASTRON JA, OKAZAKI H, GROOVER RV. (1975). Chronic inflammatory demyelinating polyradiculoneuropathy. Mayo Clinic Proc, 50: 621-637.
18. FERRIBY D, STOJKOVIC T, DE SEZE J, HURTEVENT JF, VERMERSCH P. (2002). Polyradiculonévrite chronique révélatrice d'une sarcoïdose. Rev Neurol (Paris), 158: 357-360.
19. FOURNIER E. (1998). Examen électromyographique et étude de la conduction nerveuse. Paris. EM Inter.
20. GIBBELS E, DIEDERICH N. (1988). Human immunodeficiency virus (HIV)-related chronic relapsing inflammatory demyelinating polyneuropathy with multifocal unusual onion bulbs in sural nerve biopsy. A clinicomorphological study with qualitative and quantitative light and electron microscopy. Acta Neuropathol (Ber), 75: 529-534.
21. GRIGGS JJ, COMMICHAU CS, RAPOPORT AP, GRIGGS RC. (1997). Chronic inflammatory demyelinating polyneuropathy in non-Hodgkin's lymphoma. Am J Hematol, 54: 332-334.
22. HAQ RU, PENDLEBURY WW, FRIES TJ, TANDAN R. (2003). Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients. Muscle Nerve, 27: 465-470.
23. HAQ RU, FRIES TJ, PENDLEBURY WW, KENNY MJ, BADGER GJ, TANDAN R. (2000). Chronic inflammatory demyelinating polyradiculoneuropathy: a study of proposed electrodiagnostic and histologic criteria. Arch Neurol, 57: 1745-1750.
24. HERMOSILLA E, LAGUENY A, VITAL C, VITAL A, FERRER X, STECK A et al. (1996). Peripheral neuropathy associated with monoclonal IgG of undetermined significance: clinical, electrophysiologic, pathologic and therapeutic study of 14 cases. J Peripher Nerv Syst, 1: 139-148.
25. HUGHES R, BENSA S, WILLISON H, VAN DEN BERGH P, COMI G, ILLA I. et al. AND THE INFLAMMATORY NEUROPATHY CAUSE AND TREATMENT (INCAT) GROUP. (2001). Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol, 50: 195-201.
26. INABA A, YOKOTA T, OTAGIRI A, NISHIMURA T, SAITO Y, ICHIKAWA T et al. (2002). Electrophysiological evaluation of conduction in the most proximal motor root segment. Muscle Nerve, 25: 608-611.
27. INOUE A, TSUKADA N, KOH CS, YANAGISAWA N. (1987). Chronic relapsing demyelinating polyneuropathy associated with hepatitis B infection. Neurology, 37: 1663-1666.
28. KATZ JS, SAPERSTEIN DS, GRONSETH G, AMATO AA, BAROHN RJ. (2000). Distal acquired demyelinating symmetric neuropathy. Neurology, 54: 615-620.
29. KISSEL JT. (2003). The treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Seminars in Neurology, 23: 169-179.
30. KOSKI CL. (2002). Therapy of CIDP and related immune-mediated neuropathies. Neurology, 59 (Suppl 6): S22-S27.
31. LAGUENY A, BOUILLOT S, VITAL C, FERRER X, LARRIEU JM, VITAL A. (2004). Syndrome POEMS (ou syndrome de Crow-Fukase). Rev Neurol (Paris), 160: 285-295.
32. LEWIS RA, SUMNER AJ, BROWN MJ, ASBURY AK. (1982). Multifocal demyelinating neuropathy with persistent conduction block. Neurology, 32: 958-964.
33. LUOSTARINEN L, HIMANEN SL, PIRTTILA T, MOLNAR G. (1999). Mixed connective tissue disease associated with chronic inflammatory demyelinating polyneuropathy. Scand J Rheumatol, 28: 328-330.
34. MAGDA P, LATOV N, BRANNAGAN TH 3RD, WEIMER LH, CHIN RL, SANDER HW. (2003). Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy. Arch Neurol, 60: 1755-1759.
35. MAGY L, CHASSANDE B, MAISONOBE T, BOUCHE P, VALLAT JM, LEGER JM. (2003). Polyneuropathy associated with IgG/IgA monoclonal gammopathy: a clinical and electrophysiological study of 15 cases. Eur J Neurol, 10: 677-685.
36. MAISONOBE T, CHASSANDE B, VÉRIN M, JOUNI M, LÉGER JM, BOUCHE P. (1996). Chronic dysimmune demyelinating polyneuropathy: a clinical, electrophysiological study of 93 patients. J Neurol Neurosurg Psychiatry, 61: 36-42.
37. MCCOMBE PA, POLLARD JD, MCLEOD JG. (1987). Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases. Brain, 110: 1617-1630.
38. MOLENAAR DSM, VERMEULEN M, DE HAAN RJ. (2002). Comparison of electrodiagnostic criteria for demyelination in patients with chronic inflammatory demyelinating polyneuropathy (CIDP). J Neurol, 249: 400-403.
39. MOLENAAR DSM, VERMEULEN M, DE HAAN R. (1998). Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating poly neuropathy. J Neurol Neurosurg Psychiatry, 64: 84-89.
40. NICOLAS G, MAISONOBE T, LE FORESTIER N, LEGER JM, BOUCHE P. (2002). Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve, 25: 26-30.
41. NOTERMANS NC, FRANSSEN H, EURELINGS M, VAN DER GRAFF Y, WOKKE JHJ. (2000). Diagnostic criteria for demyelinating polyneuropathy associated with monoclonal gammopathy. Muscle Nerve, 23: 73-79.
42. OH SJ, JOY JL, KURUOGLU R. (1992). "Chronic sensory demyelinating neuropathy": chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy. J Neurol Neurosurg Psychiatry, 55: 677-680.
43. OHKOSHI N, HARADA K, NAGATA H, YATO M, SHOJI S. (2001). Ataxic form of chronic inflammatory demyelinating polyradiculoneuropathy: clinical features and pathological study of the sural nerves. Eur Neurol, 45: 241-248.
44. RECHTHAND E, CORNBLATH DR, STERN BJ, MEYERHOFF JO. (1984). Chronic demyelinating polyneuropathy in systemic lupus erythematosus. Neurology, 34: 1375-1377.
45. ROPPER AH. (2003). Current treatments for CIDP. Neurology, 60 (Suppl 3): S16-S22.
46. ROTTA FT, SUSSMAN AT, BRADLEY WG, RAM AYYAR D, SHARMA KR, SHEBERT RT. (2000). The spectrum of chronic inflammatory demyelinating polyneuropathy. J Neurol Sci, 173: 129-139.
47. SABATELLI M, MADIA F, MIGNOGNA T, LIPPI G, QUARANTA L, TONALLI P. (2001). Pure motor chronic inflammatory demyelinating polyneuropathy. J Neurol, 246: 772-777.
48. SAPERSTEIN DS, KATZ JS, AMATO AA, BAROHN RJ. (2001). Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve, 24: 311-324.
49. SCHADY W, GOULDING PJ, LECKY BRF, KING RHM, SMITH CML. (1996). Massive nerve root enlargement in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry, 61: 636-640.
50. SINNREICH M, KLEIN CJ, DAUBE JR, ENGELSTAD J, SPINNER RJ, DYCK PJ. (2004). Chronic immune sensory polyradiculopathy: a possibly treatable sensory ataxia. Neurology, 63: 1662-1669.
51. THAISETTHAWATKUL P, LOGGIGIAN EL, HERRMANN DN. (2002). Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy. Neurology, 59: 1526-1532.
52. UNCINI A, DI MUZIO A, DE ANGELIS MV, GIOIA S, LUGARESI A. (1999). Minimal and asymptomatic chronic inflammatory demyelinating polyneuropathy. Clin Neurophysiol, 110: 694-698.
53. VALLAT JM, TABARAUD F, MAGY L et al. (2003). Diagnostic value of nerve biopsy for atypical chronic demyelinating polyneuropathy: evaluation of eight cases. Muscle Nerve, 27: 478-485.
54. VAN DEN BERGH PY, PIERET F. (2004). Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve, 29: 565-574.
55. VERSCHUEREN A, AZULAY JP, ATTARIAN S, BOUCRAUT J, PELLISSIER JF, POUGET J. (2005). Lewis-Sumner syndrome and multifocal motor neuropathy. Muscle Nerve, 31: 88-94.
56. VIALA K, RENIE L, MAISONOBE T, BEHIN A, NEIL J, LEGER JM, BOUCHE P. (2004). Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome. Brain, 127: 2010-2017.
57. WILLISON HJ, O'LEARY CP, VEITCH J, BLUMHARDT LD, BUSBY M, DONAGHY M et al. (2001). The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Brain, 124: 1968-1977.